Citadel Advisors’s P3 Health Partners Inc Warrant PIIIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-25,186
Closed -$2.02K – 15024
2023
Q1
$2.02K Buy
+25,186
New +$2.97K ﹤0.01% 14220
2022
Q4
– Sell
-16,525
Closed -$12K – 15312
2022
Q3
$12K Sell
16,525
-2,686
-14% -$1.93K ﹤0.01% 12231
2022
Q2
$8K Buy
19,211
+768
+4% +$907 ﹤0.01% 12631
2022
Q1
$30K Buy
18,443
+1,375
+8% +$1.34K ﹤0.01% 13105
2021
Q4
$18K Buy
17,068
+6,508
+62% +$7.88K ﹤0.01% 13599
2021
Q3
$9K Hold
10,560
– – ﹤0.01% 13689
2021
Q2
$15K Buy
+10,560
New +$10.8K ﹤0.01% 13550

Other funds holding PIIIW

Citadel Advisors's PIIIW Position: Q2 2023 in Review

Citadel Advisors sold out of P3 Health Partners Inc Warrant (PIIIW) in Q2 2023, closing a stake of 25,186 shares — an estimated $2.02K sold.

Citadel Advisors first reported a position in PIIIW in Q2 2021 and held it in 7 quarters. The position peaked at $30K in Q1 2022. 22 funds tracked by Wall St. Rank hold PIIIW as of Q2 2023.

  • Citadel Advisors reported no remaining P3 Health Partners Inc Warrant position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 25,186 P3 Health Partners Inc Warrant shares in Q2 2023, an estimated $2.02K.
  • Citadel Advisors first reported a position in P3 Health Partners Inc Warrant in Q2 2021 and held it in 7 quarters.
  • Citadel Advisors's P3 Health Partners Inc Warrant position peaked at $30K in Q1 2022.
  • 22 funds tracked by Wall St. Rank held P3 Health Partners Inc Warrant as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.